PRNB - Principia Biopharma Inc.
Previous close
100.05
0 0%
Share volume: 0
Last Updated: Fri 25 Sep 2020 06:00:00 AM CEST
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$100.05
0.00
0.00%
Summary score
43%
Profitability
25%
Dept financing
23%
Liquidity
50%
Performance
65%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-3.34%
Return on assets
-1.22%
Return on sales
0%
Return on invested capital
-511.62%
Total debt ratio
27.48%
Debt ratio change over timeo
-1.02%
Current Ratio
11.67%
Quick Ratio
0%
Cash Position Ratio
2.99%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-6.16%
Return on assets
-5.93%
Return on sales
0%
Return on invested capital
-177.6%
Total debt ratio
9.15%
Debt ratio change over timeo
-1.02%
Current Ratio
16.04%
Quick Ratio
0%
Cash Position Ratio
4.16%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
3.08%
Return on assets
2.56%
Return on sales
0%
Return on invested capital
-208.65%
Total debt ratio
8.94%
Debt ratio change over time
-1.17%
Current Ratio
17.01%
Quick Ratio
0%
Cash Position Ratio
7.85%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.88%
Return on assets
-102.45%
Return on sales
0%
Return on invested capital
135.45%
Total debt ratio
-102.39%
Debt ratio change over time
-1.02%
Current Ratio
-7.99%
Quick Ratio
0%
Cash Position Ratio
-3.83%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PRNB | FTSV | RARX | GCVRZ |
|---|---|---|---|---|
| Return on equity | -3.34% | -17.97% | -14.58% | 0% |
| Return on assets | -1.22% | -15.67% | -13.27% | 0% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | -511.62% | 161.19% | 733.8% | 0% |
| Profitability | 25% | 5% | 25% | 50% |
| Total debt ratio | 27.48% | 14.54% | 9.46% | 0% |
| Debt ratio change over time | -1.02% | -0.91% | -1% | 0% |
| Dept financing | 25% | 13% | 9% | 25% |
| Current Ratio | 16.04% | 11.14% | 20.26% | 0% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 4.16% | 5.36% | 19.67% | 0% |
| Liquididy | 49% | 17% | 50% | 0% |
| Short-term ratios | PRNB | FTSV | RARX | GCVRZ |
|---|---|---|---|---|
| Return on equity | -6.16% | -8.91% | -11.27% | 0% |
| Return on assets | -5.93% | -8.75% | -10.9% | 0% |
| Return on sales | 0% | 0% | 0% | 0% |
| Return on invested capital | -177.6% | 121.89% | 631.03% | 0% |
| Profitability | 25% | 5% | 25% | 50% |
| Total debt ratio | 9.15% | 10.61% | 6.33% | 0% |
| Debt ratio change over time | -1.02% | -0.91% | -0.99% | 0% |
| Dept financing | 22% | 25% | 15% | 25% |
| Current Ratio | 16.04% | 11.14% | 20.26% | 0% |
| Quick Ratio | 0% | 0% | 0% | 0% |
| Cash Position Ratio | 4.16% | 5.36% | 19.67% | 0% |
| Liquididy | 50% | 21% | 50% | 0% |